Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early methylene blue for microcirculation in septic shock
RBR-3rmx79qPhase 3Recruiting
- Sponsor
- Hospital Santa Casa de Curitiba
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methylene blue in septic shock and sepsis (2 arms), sponsored by Hospital Santa Casa de Curitiba. Started Dec 2025; status: recruiting.
02
Drugs
methylene blue
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on RBR-3rmx79q.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3rmx79q.